Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
McKesson
Express Scripts
Johnson and Johnson
Merck

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: maraviroc


Email this page to a colleague

« Back to Dashboard

Maraviroc

CASRN: 376348-65-1

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Moodys
Johnson and Johnson
Medtronic
McKinsey